Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Spheryx Protein Aggregate Results Presented in Prestigious Venues: Presentations at PEGS Europe and Publication in Soft Matter

Spheryx
Posted on: 26 Oct 16

NEW YORK, Oct. 26, 2016 /PRNewswire/ -- Spheryx, Inc. is pleased to announce that the company will present two posters at PEGS Europe.  The posters, entitled "A New Method for Protein Aggregate Detection: Total Holographic Characterization®" and "Distinguishing Protein Aggregates from Silicone Oil by Symmetry and Fractal Dimension" will be presented on November 3 and 4 at the EPIC SANA Lisboa Hotel, Lisbon, Portugal.  PEGS Europe, the largest European event covering all aspects of protein and antibody engineering, brings together a cross section of protein scientists from leading biologics producers and research institutions.  Additional information about PEGS Europe can be found at www.pegsummiteurope.com.  Spheryx also announces the publication of an article entitled "Holographic Characterization of Colloidal Fractal Aggregates" in Soft Matter (DOI: 10.1039/C6SM01790H) in collaboration with Prof. David Grier and his research group at New York University.  This paper demonstrates that Total Holographic Characterization® can assess the shape, size and composition of pharmaceutically important protein aggregates as well as other irregularly shaped particles.

About Spheryx, Inc.
Spheryx, Inc. is a privately held analytical services and instruments company developing Total Holographic Characterization®.  The breakthrough proprietary technology, based on holographic video microscopy, enables the real-time, sub-microscopic characterization of multi-component colloidal materials.  Applications include research and development, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, safety and cost savings.  For more information please visit the company's website at www.spheryx.solutions

Note: This news release contains forward-looking statements regarding future events.  These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially.

Contact:
Laura Philips, CEO
laphilips@spheryx.solutions 
607-738-0100

For more information:
www.spheryx.solutions

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.